This study demonstrates faster deuterium metabolic imaging using low-rank and subspace reconstruction, potentially improving liver cancer assessment.
Motivation: Long acquisition times limit the clinical use of Deuterium Metabolic Imaging (DMI) for liver metastases assessment, as it reduces efficiency and feasibility in routine clinical practice. Goal(s): This study demonstrates that additional acceleration of DMI can be achieved by combining Hamming weighted-acquisition with retrospective undersampling, potentially reducing acquisition times without compromising data quality. Approach: DMI data were acquired with weighted-acquisition and retrospectively undersampled to R=1.8 from patients (hepatic tumours). Low-rank and subspace reconstruction was applied to evaluate SNR and CRLB compared to FFT. Results: The low-rank and subspace reconstruction achieved an approximately 3-fold SNR increase and lower CRLB, enabling practical and accelerated DMI. Impact: This study enables faster DMI of the abdomen by combining Hamming weighted acquisition with low-rank and subspace reconstruction. The results pave the way for advanced metabolic imaging applications, potentially enhancing liver cancer assessment and treatment planning in clinical settings.
No takes yet. Share an insight, caveat, or question.
Nam et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: